Arizona Bioscience News: Flinn, Xcellerant Ventures partnership; Dementia app; TGen teaches kids science 

May 25, 2023

By Jessica Vaile

Flinn Foundation to back Scottsdale VC fund in commitment to bioscience startups / Phoenix Business Journal (AZ Inno)

The Flinn Foundation is entering the venture capital world, as a limited partner with Scottsdale-based Xcellerant Ventures, to advance its mission of supporting bioscience and health care-focused startups. Read more: VC partners with Flinn Foundation to fuel growth in Arizona bioscience and healthcare sectors

Tucson hospitals use robotics to expedite lung cancer treatment / Arizona Daily Star

Banner-University Medical Center and Northwest Medical Center in Tucson have added robotic-assisted bronchoscopy technology, allowing doctors to diagnose lung cancer and determine the extent of its spread in a single procedure.

Tucson health care turns to alternative and high-tech solutions / Inside Tucson Business

Together, the CEOs of Tucson’s largest hospital and its largest community health center network point to a new reality for the health care industry, where the demand for quality health care exceeds the supply of professionals to provide it—and where the means to fund the whole system is continually in flux.

UK startup eyes Phoenix for new HQ as it expands dementia app / Phoenix Business Journal (AZ Inno)

Memory Lane Games, a British startup that designed an app for those living with dementia, is in town meeting with Mayo Clinic, Sun Health and memory care facilities while considering moving its corporate headquarters to Phoenix.

TGen researchers lead STEM program at Kinsey Elementary / Arizona Daily Sun

Translational Genomics Research Institute researchers visit a Flagstaff elementary school each week to lead third- through fifth-graders in hands-on science activities after school that culminates with a trip to TGen’s labs.

Survey: People split on whether to trust AIs in medicine / KJZZ

University of Arizona researchers surveyed almost 2,500 people to find out how comfortable people are with AI diagnosis and treatment. About 53% of participants said they aren’t convinced AI diagnoses are trustworthy.

Upcoming Events

August 17: AZBio Fall Reception at C-Path